Gabapentin Capsule
Product Images NDC 69292-640

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69292-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amici Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100-100 (100 100)

Gabapentin Capsules, USP 100 mg packaging label showing the product name, dosage strength, and form. The label includes storage instructions, manufacturer details (Saffron Laboratories Pvt. Ltd.), distributor information (Amici Pharma, Inc.), an NDC number (62922-640-01), and a note to dispense the medication guide separately. It specifies Rx only and a package count of 100 capsules.*

FDA Label Image

100-1000 (100 1000)

Label for Gabapentin Capsules USP, 100 mg, by Amici Pharma, Inc. The label shows the dosage form as capsules, quantity of 1000 capsules, and includes storage instructions between 20°C to 25°C. It notes the drug is manufactured by Stallion Laboratories Pvt. Ltd. in India, with a National Drug Code (NDC) of 69292-640-10 and directions for pharmacist dispensing of Medication Guide separately to each patient.*

FDA Label Image

100-500 (100 500)

Gabapentin Capsules, USP 100 mg oral capsules label from Amici Pharma, Inc. The label includes the NDC 69292-640-50, dosage strength, storage instructions, manufacturer details, and a barcode. It indicates prescription use, package size of 500 capsules, and directs to see the package insert for full prescribing information.*

FDA Label Image

300-100 (300 100)

Label for Gabapentin Capsules, USP 300 mg by Amici Pharma, Inc. The label includes the NDC number 69292-641-01. It states each capsule contains 300 mg Gabapentin and the package contains 100 capsules. Storage instructions specify 20ºC to 25ºC with permitted excursions and recommend child-resistant containers. Label also includes manufacturing details of Stallion Laboratories Pvt. Ltd., India.*

FDA Label Image

300-1000 (300 1000)

Gabapentin Capsules, USP 300 mg oral dosage form presented on a white label. The label indicates a package of 1000 capsules distributed by Amici Pharma, Inc., made in India by Stallion Laboratories Pvt. Ltd. It provides storage instructions, a National Drug Code (NDC 69292-641-10), and advises dispensing the medication guide to patients.*

FDA Label Image

300-500 (300 500)

Gabapentin Capsules, USP 300 mg oral capsules label from Amici Pharma, Inc. The label indicates a package size of 500 capsules with NDC 69292-641-50. It includes storage instructions, dispensing requirements, and manufacturer info (Stallion Laboratories Pvt. Ltd., India). The label directs pharmacists to dispense the medication guide separately.*

FDA Label Image

400-100 (400 100)

Gabapentin Capsules, USP 400 mg oral capsules label from Amici Pharma, Inc. The label includes storage instructions (20°C to 25°C), child-resistant packaging warnings, and states the product is Rx only with 100 capsules per package. It also lists the manufacturer as Stallion Laboratories Pvt. Ltd. in India and features a barcode and lot expiration details.*

FDA Label Image

400-1000 (400 1000)

Label for Gabapentin Capsules, USP 400 mg by Amici Pharma, Inc. The label states each capsule contains 400 mg of Gabapentin. Provides storage instructions for controlled room temperature and child-resistant container dispensing. The label indicates a package size of 1000 capsules and includes manufacturing details from Stallion Laboratories Pvt. Ltd., India.*

FDA Label Image

400-500 (400 500)

Label for Gabapentin Capsules, USP 400 mg by Amici Pharma, Inc. The label shows each capsule contains 400 mg of gabapentin. It includes storage instructions, dispensing guidance, a barcode, and manufacturer information (Stallion Laboratories Pvt. Ltd., India). The package contains 500 capsules for oral use, prescription only.*

FDA Label Image

Image Description (Gabapentincapsules 01)

A pharmacokinetic formula showing creatinine clearance (CLCr) calculation. It expresses CLCr as a function of age in years, weight in kilograms, and serum creatinine in mg/dL, with a multiplication factor of 0.85 for female patients.*

FDA Label Image

Chemical Structure (Gabapentincapsules 02)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino group and a carboxylic acid group.*

FDA Label Image

Figure 1 (Gabapentincapsules 03)

A line graph depicting mean pain score over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows the mean pain score from 0 to 10. The graph indicates a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a decreasing trend in pain score compared to placebo.*

FDA Label Image

Figure 2 (Gabapentincapsules 04)

A line graph depicting mean pain scores over seven weeks for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, while the y-axis shows the mean pain score from 0 to 10. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 3 (Gabapentincapsules 05)

Bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' illustrating results for two studies. Study 1 shows 12% for placebo (PBO) and 29% for Gabapentin 3600 mg (GBP 3600). Study 2 shows 14% for placebo (PBO), 32% for Gabapentin 1800 mg (GBP 1800), and 34% for Gabapentin 2400 mg (GBP 2400). Statistical significance markers indicate p < 0.01 and p < 0.001 for certain comparisons.*

FDA Label Image

Figure 4 (Gabapentincapsules 06)

A scatter plot comparing percentage difference by daily dose (mg) in three studies labeled a, b, and c. The x-axis shows daily dose amounts of 600, 900, 1200, and 1800 mg. The y-axis indicates percentage difference ranging from 2% to 22%. Study a data points are shown in black squares, study b in gray squares, and study c in white squares.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.